Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Mammalian cell-cycle control by antimitogenic signals involves p21Cip1/WAF1 (refs 1-4), p27Kip1 (refs 5, 6) and p57Kip2 (refs 7, 8), a family of proteins that bind to and inhibit cyclin-dependent kinases (CDKs) required for initiation of S phase. The protein p21 also binds to the DNA polymerase delta processivity factor, proliferating-cell nuclear antigen (PCNA), and inhibits in vitro PCNA-dependent DNA replication. The CDK and PCNA inhibitory activities of p21 are shown here to be functionally independent and to reside in separate protein domains. The PCNA binding and inhibitory activities, which are not observed with p27 or p57, reside in the C-terminal domain of p21, whereas the CDK inhibitory activity resides in the conserved N-terminal domains of these proteins. When separately overexpressed in mammalian cells, the CDK and PCNA inhibitory domains prevent DNA replication, demonstrating a dual function of p21 as a cell-cycle inhibitor in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [150]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [150]
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
In the citing paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [38]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Self-citationp27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Lee, M. H., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Self-citation
Research works printed but not linked: 1
- Kelman, Z., Naktinis, V. & O'Donnell, M. Meth. Enzym. (in the press).
Cited by
Items 501–548 of 548
Reovirus Oncolysis- Role of cyclin-dependent kinase inhibitor 1
(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.750
“The dual effect on cell cycle regulatory proteins is mediated in the p21 sequence via distinct interaction sites for cyclin-Cdk complexes (n-terminal residue 45-60) and for PCNA (c-terminal 142-163) ([19]).”
BackgroundAdenovirus and its interaction with host cell proteins
Carr, S. (2007) · St Andrews Research Repository (St Andrews Research Repository)
Regulation of Mammalian G1 Cyclin Dependent Kinase Complexes by Transforming Growth Factor-ß
Taipale, M. (1999) · Helda - University of Helsinki Institutional Repository
The P21 Protein and DNA Damage
Rudolph, J. H. (2008) · GSI Repository (German Federal Government) · doi:10.26083/tuprints-00000979
Marques, Y. (2006) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.23.2006.tde-19032007-170028
Mécanisme de leucémogénèse par les oncogènes SCL et LMO1
Tremblay, M. R. (2009) · doi:10.71781/27559
Wang, E., Marcotte, R., Papaconstantinou, H. T., & Papaconstantinou, J. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)04032-9
Fujita, T., Terada, S., Ueda, H., Nagamune, T., & Suzuki, E. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46865-4_30
Thrombospondin Inhibits VEGF-Induced Endothelial Survival and Cell Cycle Progression
Gupta, K., Schwartz, R. E., Gupta, P., & Hebbel, R. P. (2009) · The Open Circulation & Vascular Journal · doi:10.2174/1877382600902010001
“More than 75%-80% of CDK2 and cyclin A are associated with both p21 and p27 and the cleaved fragments of p21 and p27 orchestrate CDK2 inhibition [39, 41-43].”
Corroyer, S., Schittny, J. C., Djonov, V., Burri, P. H., & Clément, A. (2002)
Studies of the interaction between human and viral proteins
Ramaiah, V. (2012)
Mdm, P. (2006)
Inhibition of Tumor Growth by Grape Seed Extract (GSE).
Teh, C. C. (2011)
der Naturwissenschaften, D. (2008)
Role of the transcription factor NFAT5 in mammalian cell cycle regulation
Drews‐Elger, K. (2008) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
An immunohistochemical and microsatellite analysis of nephroblastomas.
Govender, D. (2008) · ResearchSpace (University of KwaZulu-Natal)
Anti-cancer implications of small molecule compounds targeting proliferating cell nuclear antigen
McKillip, K. D., & Kelsey, L. J. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Tournier, S., Leroy, D., Goubin, F., & Ducommun, B. (1996)
Strömblad, S., Becker, J. C., Yebra, M., Brooks, P. C., & Cheresh, D. A. (1996)
AKT EM NEOPLASIAS BENIGNAS DE GLÂNDULA SALIVAR
Paulo, S. (2006)
p27/Kipl Mutation Found in Breast Cancer1
Spirin, K. S., Simpson, J. F., Takeuchi, S., Kawamata, N., Miller, C. W., & Koeffler, H. P. (1996)
Inhibitors of the CipjKip Family
Hengst, L. (1998)
Regulation of the cell cycle by (OK inhibitors
Soos, T. J., & Kiyokawa, H. (1998)
p53 mutational analysis in laryngeal squamous cell carcinoma, results of full-length gene sequencing
Saunders, E. (1999) · Library and Archives Canada (Government of Canada)
Bhaduri, S. (2014) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2130g
Quantitative Analysis of a Cell Cycle Checkpoint in Xenopus laevis Cell-Free Egg Extracts
Auckland, I. (2005) · VTechWorks (Virginia Tech)
Mechanisms of cell cycle remodeling at the MBT during the development of Xenopus laevis embryos
Petrus, M. J. (2002) · VTechWorks (Virginia Tech)
Martín‐Renedo, J. (2011) · Buleria (Universidad de León) · doi:10.18002/10612/1751
Generating Isogenic Models of Li-Fraumeni Syndrome and Restoring p53 using CRISPR
Tran, J. (2020) · TSpace (University of Toronto)
Han, J., Xu, G., Dong, Q., Jing, G., Liu, Q., & Liu, J. (2022) · All Life · doi:10.1080/26895293.2021.2024893
Dawn of a new era in sponge biotechnology
Hesp, K. (2021) · doi:10.18174/540280 · Cited by 3
(2009) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420078930.bmatt
(1997) · Elsevier eBooks · doi:10.1016/b978-012639875-5/50017-0
Archer, S. Y., & Hodin, R. A. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0013
The Role of miRNAs and Alternative Polyadenylation in Modulating the P53 Response
Browning, J. W. L. (2018) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2018-13260
“DREAM complex formation blocks proliferating nuclear antigen (PCNA), a critical component in DNA replication (Deng et al., 1995; Bunz et al., 1998; Luo et al., 1995; Chen et al., 1995; Harrington et al., 1998).”
BackgroundThe MDM2 oncoprotein antagonizes Poly(ADP-ribosyl)ation
Giansanti, C. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9741
Falco, G. D., Soprano, C. M., & Giordano, A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-401-6_1
Ghrib, M. A., Dayhoff, G. W., Chahtour, C., Rodrigues, C. M., Youssef, A., Schillaci, G., Gautreau, G., Henry, C., Uversky, V. N., Rigolet, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.19.660543
DNA Topoisomerases as Drug Targets and Cell Cycle Checkpoint Effector Molecules
Smith, P. J., Blunt, N., & Souès, S. (1996) · Springer eBooks · doi:10.1007/978-3-642-61115-5_11
Stabilization of cyclin D3 protein by CDKN1A (p21Cip/Waf1) in butyrate-treated cells
Ghrib, M. A., Dayhoff, G. W., Chahtour, C., Rodrigues, C. M., Youssef, A., Schillaci, G., Gautreau, G., Henry, C., Uversky, V. N., Rigolet, P., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02767-6
“Structurally, CDKN1A is highly intrinsically disordered, possessing distinct regions dedicated to binding CCND-CDK complexes and proliferating cell nuclear antigen (PCNA) [45, 46].”
Bachelet, J.-T. (2020) · theses.fr (ABES) · doi:10.70675/3c3e2db9zfde9z4fa4zab19z1ce729143190
Syntheses and biological applications of phosphorus dendrimers and dendrons
Chen, L. (2020) · theses.fr (ABES) · doi:10.70675/89db4c98ze5cez49bbzbb85zf5a7e511a965
Control of ependymal cell differentiation by the mTOR signaling pathway
Srivastava, A. (2021) · theses.fr (ABES) · doi:10.70675/0e4dc286zfb40z4d2bza4cdzd6fdff1cc2e8
Pesenti, L. (2024) · theses.fr (ABES) · doi:10.70675/04a80eeazdd63z42e4zbd7fz230cf5dbc199
Qiu, H., Fan, Z., Liu, D., Deng, L., Wang, X., Yang, Y., Yang, T., Tian, F., Hao, J., Zhang, Q., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05166-3
Kivinen, L. (1999) · Helda - University of Helsinki Institutional Repository · Cited by 1
The Role of ERK5 in Cell Proliferation
Madrigal, D. P. (2013) · Research Explorer (The University of Manchester)
Metadata
- Authors
- Luo, Y., Hurwitz, J., & Massagué, J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- ORCID
- Massagué, Joan
- Venue
- Nature
- Published
- 1995-05
- Volume
- 375
- Issue
- 6527
- Pages
- 159-161
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2030231219
- Cited by
- 549
- References
- 18
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 11 · 2019: 6 · 2018: 8 · 2017: 13 · 2016: 12 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 16
- FWCI
- 23.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cyclin-dependent kinases, proliferating cell nuclear antigen, C-terminal domain, cell cycle inhibition, DNA replication inhibition, p27, p57KIP2, S phase entry
- MeSH terms
- Amino Acid Sequence, Animals, Binding Sites, Cell Cycle, DNA, Humans, Molecular Sequence Data, Recombinant Fusion Proteins, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.